| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2787 | 2015 |
| Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma M Krauthammer, Y Kong, BH Ha, P Evans, A Bacchiocchi, JP McCusker, ... Nature genetics 44 (9), 1006-1014, 2012 | 1354 | 2012 |
| In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma FA Karreth, Y Tay, D Perna, U Ala, SM Tan, AG Rust, G DeNicola, ... Cell 147 (2), 382-395, 2011 | 739 | 2011 |
| Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. R Halaban, R Langdon, N Birchall, C Cuono, A Baird, G Scott, ... The Journal of cell biology 107 (4), 1611-1619, 1988 | 622 | 1988 |
| Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas K Hoek, DL Rimm, KR Williams, H Zhao, S Ariyan, A Lin, HM Kluger, ... Cancer research 64 (15), 5270-5282, 2004 | 611 | 2004 |
| Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. BS Kwon, AK Haq, SH Pomerantz, R Halaban Proceedings of the National Academy of Sciences 84 (21), 7473-7477, 1987 | 569 | 1987 |
| Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure S Premi, S Wallisch, CM Mano, AB Weiner, A Bacchiocchi, K Wakamatsu, ... Science 347 (6224), 842-847, 2015 | 551 | 2015 |
| Combination therapy with anti–CTLA-4 and anti–PD-1 leads to distinct immunologic changes in vivo R Das, R Verma, M Sznol, CS Boddupalli, SN Gettinger, H Kluger, ... The Journal of Immunology 194 (3), 950-959, 2015 | 484 | 2015 |
| Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas M Krauthammer, Y Kong, A Bacchiocchi, P Evans, N Pornputtapong, ... Nature genetics 47 (9), 996-1002, 2015 | 456 | 2015 |
| Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients MF Sanmamed, JL Perez-Gracia, KA Schalper, JP Fusco, A Gonzalez, ... Annals of Oncology 28 (8), 1988-1995, 2017 | 427 | 2017 |
| Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab J Yuan, M Adamow, BA Ginsberg, TS Rasalan, E Ritter, HF Gallardo, Y Xu, ... Proceedings of the National Academy of Sciences 108 (40), 16723-16728, 2011 | 406 | 2011 |
| PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells R Halaban, W Zhang, A Bacchiocchi, E Cheng, F Parisi, S Ariyan, ... Pigment cell & melanoma research 23 (2), 190-200, 2010 | 401 | 2010 |
| VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors … T Cohen, H Gitay-Goren, R Sharon, M Shibuya, R Halaban, BZ Levi, ... Journal of Biological Chemistry 270 (19), 11322-11326, 1995 | 400 | 1995 |
| UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. DB Bregman, R Halaban, AJ Van Gool, KA Henning, EC Friedberg, ... Proceedings of the National Academy of Sciences 93 (21), 11586-11590, 1996 | 394 | 1996 |
| Early B cell changes predict autoimmunity following combination immune checkpoint blockade R Das, N Bar, M Ferreira, AM Newman, L Zhang, JK Bailur, A Bacchiocchi, ... The Journal of clinical investigation 128 (2), 715-720, 2018 | 352 | 2018 |
| bFGF as an autocrine growth factor for human melanomas. R Halaban, BS Kwon, S Ghosh, A Baird Oncogene research 3 (2), 177-186, 1988 | 348 | 1988 |
| Regulation of tyrosinase in human melanocytes grown in culture. R Halaban, SH Pomerantz, S Marshall, DT Lambert, AB Lerner The Journal of cell biology 97 (2), 480-488, 1983 | 347 | 1983 |
| Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032 JC Rubinstein, M Sznol, AC Pavlick, S Ariyan, E Cheng, A Bacchiocchi, ... Journal of translational medicine 8, 1-3, 2010 | 327 | 2010 |
| bFGF is the putative natural growth factor for human melanocytes R Halaban, S Ghosh, A Baird In vitro cellular & developmental biology 23, 47-52, 1987 | 326 | 1987 |
| Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis BJ Longley Jr, GS Morganroth, L Tyrrell, TG Ding, DM Anderson, ... New England Journal of Medicine 328 (18), 1302-1307, 1993 | 325 | 1993 |
Stephan AriyanProfessor of Surgery, Yale UniversityVerified email at yale.edu
